Showing results (181-190 of 780) with videos related to
Sort By:
Pageof 78
Heart Disease (Hagerstown, Md.)|June 5, 2003
Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulationDomenic Sica, William H Frishman, Neil ManowitzCardiology in Review|December 12, 2003
Heat shock proteins in cardiovascular disease a new therapeutic targetMita Gupta, Christos Vavasis, William H FrishmanCardiology in Review|October 16, 2009
The emerging role of apelin in cardiovascular disease and healthRobin Quazi, Chandrasekar Palaniswamy, William H FrishmanCardiology in Review|June 19, 2025
Leptin for Obesity: Previous Failures, Promising FutureAvraham Marcucci, Jamie Mullally, William H FrishmanCardiology in Review|March 31, 2026
Danon Disease: Clinical Manifestations, Pathophysiology, and TreatmentMargot Richards, Lauren Tetelbaun, William H FrishmanCardiology in Review|October 6, 2022
Semaglutide for Weight Loss: Was It Worth the Weight?Joel Novograd, Jaime Mullally, William H FrishmanCardiology in Review|February 3, 2011
RESPeRATE: nonpharmacological treatment of hypertensionMala Sharma, William H Frishman, Kaushang GandhiCardiology in Review|December 15, 2004
Phytoestrogens as cardioprotective agentsDenise Park, Tiffany Huang, William H FrishmanCardiology in Review|October 17, 2008
Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failureBenjamin Erickson, Kirk Sperber, William H FrishmanHeart Disease (Hagerstown, Md.)|January 29, 2003
Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular diseaseEnzo Ragucci, Joel Zonszein, William H FrishmanPageof 78